IP Library Granted Patent US 11,090,263
Granted Patent B2
US 11,090,263 · App. 15/986,362 · Granted Aug 17, 2021

Tableted chewing gum suitable for active pharmaceutical ingredients

Inventor: Helle Wittorff (Vejle Øst, DK)
Assignee: FERTIN PHARMA A/S
A61K9/0058A61K9/2018A61K9/2027A61K9/2086A61K9/2095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,090,263
App. No.
15/986,362
Granted
Aug 17, 2021
Kind
B2
Abstract

The invention relates to a tableted chewing gum suitable for active pharmaceutical ingredients, the chewing gum comprising a population of particles, the population of particles comprising a) directly compressible (DC) sugar alcohol particles, b) non-directly compressible (non-DC) sugar alcohol particles and c) particles comprising gum base, the gum base comprising at least 5% by weight of elastomer.

Claims (20)

1. A tableted chewing gum suitable for active pharmaceutical ingredients, the tableted chewing gum comprising a population of particles and having been formed by direct compression, the population of particles comprising a) directly compressible (DC) sugar alcohol particles, b) non-directly compressible (non-DC) sugar alcohol particles and c) DC particles comprising gum base, the gum base comprising at least 5% by weight of elastomer, wherein the non-DC sugar alcohol particles provide the tableted chewing gum with a plurality of discrete non-DC areas embedded in a matrix comprising the DC sugar alcohol particles, that result in induced saliva generation upon mastication of the tableted chewing gum, wherein the non-DC sugar alcohol particles have not been granulated prior to tableting, and wherein the non-DC sugar alcohol particles have the average size at least 50 μm larger than the average size of the DC sugar alcohol particles.

2. The tableted chewing gum according to claim 1 , wherein said population of particles, including a), b) and c), is comprised in a first tableted module of the tableted chewing gum and combined with a second population of particles that is comprised in a second tableted module of the tableted chewing gum.

3. The tableted chewing gum according to claim 1 , wherein a) and b) is comprised in a first tableted module of the tableted chewing gum and c) is comprised in a second tableted module of the tableted chewing gum, wherein the first tableted module of the tableted chewing gum is free of gum base.

4. The tableted chewing gum according to claim 1 , wherein the tableted chewing gum comprises at least 20% by weight of gum base.

5. The tableted chewing gum according to claim 1 , wherein the non-DC sugar alcohol particles are selected from the group consisting of non-DC particles of erythritol, non-DC particles of maltitol, non-DC particles of xylitol, and combinations thereof.

6. The tableted chewing gum according to claim 1 , wherein the non-DC sugar alcohol particles are non-DC erythritol particles.

7. The tableted chewing gum according to claim 1 , wherein the tableted chewing gum comprises said non-DC sugar alcohol particles in an amount of at least 10% by weight of the tableted chewing gum.

8. The tableted chewing gum according to claim 1 , wherein saliva generation upon the mastication of the tableted chewing gum is induced compared to a tableted chewing gum where the discrete non-DC areas are based on DC sugar alcohol particles.

9. The tableted chewing gum according to claim 1 , wherein the tableted chewing gum generates more than 1.0 mL saliva per 10 seconds within 30 seconds from onset of mastication.

10. The tableted chewing gum according to claim 1 , wherein the tableted chewing gum generates more than 0.5 mL saliva per 10 seconds within a period from 30 to 90 seconds from onset of mastication.

11. The tableted chewing gum according to claim 1 , wherein the tableted chewing gum further comprises an active pharmaceutical ingredient.

12. The tableted chewing gum according to claim 1 , wherein the tableted chewing gum further comprises an oral care agent in an amount of at least 0.1% by weight of the tableted chewing gum.

13. The tableted chewing gum according to claim 1 , wherein the tableted chewing gum further comprises dentifrice in an amount of at least 0.1% by weight of the tableted chewing gum.

14. The tableted chewing gum according to claim 1 , wherein the tableted chewing gum does not comprise an orally disintegrating tablet (ODT) module.

15. A tableted chewing gum suitable for active pharmaceutical ingredients, the tableted chewing gum comprising a population of particles and having been formed by direct compression, the population of particles comprising a) directly compressible (DC) sugar alcohol particles, b) non-directly compressible (non-DC) sugar alcohol particles and c) DC particles comprising gum base, the gum base comprising at least 5% by weight of elastomer, wherein the non-DC sugar alcohol particles provide the tableted chewing gum with a plurality of discrete non-DC areas embedded in a matrix comprising the DC sugar alcohol particles, wherein the non-DC sugar alcohol particles have not been granulated prior to tableting, and wherein the non-DC sugar alcohol particles have the average size at least 50 μm larger than the average size of the DC sugar alcohol particles.

16. The tableted chewing gum according to claim 15 , wherein the tableted chewing gum has a weight ratio between said non-DC sugar alcohol particles and said DC sugar alcohol particles that is between 0.3 and 1.2.

17. A tableted chewing gum suitable for active pharmaceutical ingredients, the tableted chewing gum comprising a population of particles and having been formed by direct compression, the population of particles comprising a) directly compressible (DC) sugar alcohol particles, b) non-directly compressible (non-DC) sugar alcohol particles and c) DC particles comprising gum base, the gum base comprising at least 5% by weight of elastomer, wherein the tableted chewing gum does not comprise nicotine, wherein the non-DC sugar alcohol particles provide the tableted chewing gum with a plurality of discrete non-DC areas embedded in a matrix comprising the DC sugar alcohol particles, wherein the non-DC sugar alcohol particles have not been granulated prior to tableting, and wherein the non-DC sugar alcohol particles have the average size at least 50 μm larger than the average size of the DC sugar alcohol particles.

18. The tableted chewing gum according to claim 17 , wherein said population of particles, including a), b) and c), is comprised in a first tableted module of the tableted chewing gum and combined with a second population of particles that is comprised in a second tableted module of the tableted chewing gum.

19. The tableted chewing gum according to claim 17 , wherein a) and b) is comprised in a first tableted module of the tableted chewing gum and c) is comprised in a second tableted module of the tableted chewing gum, wherein the first tableted module of the tableted chewing gum is free of gum base.

20. The tableted chewing gum according to claim 17 , wherein the tableted chewing gum comprises said non-DC sugar alcohol particles in an amount of at least 10% by weight of the tableted chewing gum.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2018
From: WITTORFF, HELLE
To: FERTIN PHARMA A/S
Reel/Frame 046258/0419 →
Continuity (1)
Related Publication 20190358159A1 · Nov 28, 2019
Cited By (2)
US 12,295,412 US 12,484,617